Phase I trial of TL 118 in patients with cancer.
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2012
At a glance
- Drugs TL 118 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 16 Feb 2012 Status changed from not stated to completed.
- 14 Feb 2012 New trial record